#BreastCancer #Pfizer #CancerResearch
www.aol.com
Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial
March 17 (Reuters) - Pfizer said on Tuesday its experimental combination reduced the risk of disease progression or death by 40% in patients with breast cancer.